Aprogen Biologics Inc. (KRX:003060)
267.00
-11.00 (-3.96%)
Mar 18, 2026, 3:30 PM KST
-65.37% (1Y)
| Market Cap | 52.75B -67.3% |
| Revenue (ttm) | 74.91B +10.1% |
| Net Income | -194.29B |
| EPS | -983.23 |
| Shares Out | 197.57M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 994,758 |
| Average Volume | 4,662,560 |
| Open | 280.00 |
| Previous Close | 278.00 |
| Day's Range | 265.00 - 281.00 |
| 52-Week Range | 265.00 - 840.00 |
| Beta | -0.16 |
| RSI | 22.86 |
| Earnings Date | Mar 23, 2026 |